Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Figure 2: Adjusted Mean Change from Baseline Over Time in HbA1c (%) in a 24-Week Active-Controlled Trial of Dapagliflozin Initial Combination Therapy with Metformin HCl Extended-Release in Adults with Type 2 Diabetes Mellitus In the second trial (NCT00643851), 603 patients were randomized to 1 of 3 treatment arms following a 1-week lead-in period: dapagliflozin 5 mg plus metformin HCl extended-release (up to 2,000 mg/day), dapagliflozin 5 mg plus placebo, or metformin HCl extended-release (up to 2,000 mg/day) plus placebo
Expert Rev Neurother (2017) 17(1):5975
One of the cornerstones in therapy for the prevention of acute cardiovascular events in patients with high plasma LDL-c is statins
Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: The SURMOUNT-4 randomized clinical trial
Affordability: Doctronic.ai offers telehealth visits for under $40
Surprisingly, 1 in 7 GLP-1 users (14%) began treatment without a prescription, including 19% of millennials the highest of any generation
US$ 20.35
US$ 21.26
US$ 25.74
US$ 26.59
US$ 25.77
US$ 24.24
